ASH Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Recurring Qualified-input DemandAshland’s ingredients become qualified inputs in customer formulations and production processes, which can make replacement costly and support repeat purchasing. This embedded role, combined with technical assistance and application support, strengthens customer retention and gives differentiated products more durable revenue potential.
Life Sciences And Personal Care GrowthGrowth in Life Sciences and Personal Care provides evidence of demand in markets where Ashland supplies specialized ingredients rather than only commoditized chemicals. Continued pharmaceutical volume expansion, biofunctional growth, and skincare momentum can improve mix and support more resilient growth over coming quarters.
Strong Cash Generation And LiquidityPositive operating and free cash flow give Ashland internal funding capacity for operations, investment, and debt service. The latest liquidity and leverage metrics further support financial flexibility, while inventory reduction and strong quarterly cash conversion indicate that improving earnings are translating into cash.
Bears Say
Volatile ProfitabilityThe sharp move from a substantial FY2025 loss to modest TTM profitability shows that Ashland’s earnings base remains inconsistent. With only about a 4% TTM net margin, relatively small changes in production, costs, pricing, or mix could materially affect profits and reduce confidence in sustained returns.
Manufacturing Disruptions Pressure MarginsOperational disruptions have already reduced profitability and the recovery is not immediate, because Hopewell ramp rates and other productivity initiatives require additional quarters. This delays the benefit of optimization programs and leaves near-term margin durability dependent on successful execution.
Specialty Additives Earnings WeaknessSpecialty Additives remains exposed to weaker construction and energy demand, and the segment’s falling EBITDA despite sales growth indicates limited operating leverage. Lower fixed-cost absorption and a materially reduced margin can weigh on consolidated earnings until end-market conditions and plant utilization improve.
Ashland News
ASH FAQ
What was Ashland’s price range in the past 12 months?
Currently, no data Available
What is Ashland’s market cap?
Ashland’s market cap is $56.71B.
When is Ashland’s upcoming earnings report date?
Ashland’s upcoming earnings report date is Nov 10, 2026 which is in 40 days.
How were Ashland’s earnings last quarter?
Ashland released its earnings results on Jul 28, 2026. The company reported $17.482 earnings per share for the quarter, beating the consensus estimate of $16.882 by $0.6.
Is Ashland overvalued?
According to Wall Street analysts Ashland’s price is currently Undervalued.
Does Ashland pay dividends?
Ashland does not currently pay dividends.
What is Ashland’s EPS estimate?
Ashland’s EPS estimate is 22.08.
How many shares outstanding does Ashland have?
Ashland has 45,793,370 shares outstanding.
What happened to Ashland’s price movement after its last earnings report?
Ashland reported an EPS of $17.482 in its last earnings report, beating expectations of $16.882. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Ashland?
Currently, no hedge funds are holding shares in MX:ASH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ashland Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1,406.04 (― Upside)
$1,406.04 (― Upside)
Blogger Sentiment
Neutral
MX:ASH Sentiment 57%
Sector Average 68%
Sector Average 68%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
45.73%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-0.93%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ashland
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
ASH Company Deck
ASH Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mix of clear commercial and cash-generation strengths—broad-based revenue growth (7% YoY), strong Life Sciences and Personal Care performance, inventory reduction, improved liquidity and the successful execution of Globalize and Innovate initiatives—while also acknowledging material margin pressure from earlier production disruptions, lower adjusted EBITDA versus last year, EPS headwinds from a higher tax rate, and slower-than-expected operational improvements in certain plants (notably Hopewell/HEC). Management expects pricing realization and manufacturing improvements to support a step-up in profitability in Q4 and reaffirmed revenue and EBITDA guidance, but timing of full margin recovery remains uncertain.View all MX:ASH earnings summariesASH Stock 12 Month Forecast
Average Price Target
―Eastman Chemical
―
H.B. Fuller Company
―
Innospec
―
Stepan Company
―
Element Solutions
―